MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
56 hedge funds and large institutions have $23.8M invested in Merrimack Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 22 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $23K
Holders
56
Holding in Top 10
–
Calls
–
Puts
$23K
Top Buyers
| 1 | +$2.89M | |
| 2 | +$825K | |
| 3 | +$580K | |
| 4 |
JGC
J. Goldman & Co
New York
|
+$201K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$181K |
Top Sellers
| 1 | -$2.96M | |
| 2 | -$1.5M | |
| 3 | -$1.26M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$456K |
| 5 |
Millennium Management
New York
|
-$408K |